Profound Medical (PROF) Debt to Equity (2023 - 2025)
Profound Medical has reported Debt to Equity over the past 3 years, most recently at $0.07 for Q4 2025.
- Quarterly results put Debt to Equity at $0.07 for Q4 2025, down 12.21% from a year ago — trailing twelve months through Dec 2025 was $0.07 (down 12.21% YoY), and the annual figure for FY2025 was $0.07, down 12.21%.
- Debt to Equity for Q4 2025 was $0.07 at Profound Medical, down from $0.14 in the prior quarter.
- Over the last five years, Debt to Equity for PROF hit a ceiling of $0.23 in Q4 2023 and a floor of $0.07 in Q4 2025.
- Median Debt to Equity over the past 3 years was $0.1 (2025), compared with a mean of $0.12.
- Biggest five-year swings in Debt to Equity: crashed 66.09% in 2024 and later dropped 12.21% in 2025.
- Profound Medical's Debt to Equity stood at $0.23 in 2023, then crashed by 66.09% to $0.08 in 2024, then decreased by 12.21% to $0.07 in 2025.
- The last three reported values for Debt to Equity were $0.07 (Q4 2025), $0.14 (Q3 2025), and $0.11 (Q2 2025) per Business Quant data.